| Submission to first decision
(The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor) Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date. |
3 weeks |
|---|---|
| Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) | 6 weeks |
| Submission to final decision (The average time from manuscript submission to the final editorial decision) | 16 weeks |
| Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) | 24 weeks |
ACTA Pharmaceutica Sciencia
2023 , Vol 61 , Num 4
A cross-sectional study on the knowledge of pharmacists about Alzheimer"s Disease: enhancing services for patients and caregivers
1 Clinical Pharmacy Department, Faculty of Pharmacy, Bezmialem Vakif University, Istanbul, TürkiyeDOI : 10.23893/1307-2080.APS6123 Viewed : 6629 - Downloaded : 2369 Alzheimer"s disease (AD) is a progressive neurodegenerative disorder impacting cognitive function and daily activities. Pharmacists" accessibility enables them to contribute to rational drug use, monitor interactions, and educate patients and caregivers, improving health outcomes. This study investigates pharmacists" knowledge of AD. A descriptive study in Türkiye utilized a web-based questionnaire with demographic questions and the Alzheimer"s Disease Knowledge Scale (ADKS). 185 participants (72.43% female, mean age 36.9±11.9) exhibited significant knowledge of Alzheimer"s disease (mean ADKS score: 7.48±1.18). Scores varied across factors like gender, age groups, professional experience, and geographical region. Statistically significant correlations were found between these factors and specific domains of AD knowledge. AD necessitates specialized care, and pharmacists" services improve health outcomes for patients and families. Cognitive pharmacy services for complex treatment regimens benefit AD patients and their relatives. A multidisciplinary approach is crucial in effectively addressing the impact of AD and providing optimal treatment. Keywords : Alzheimer"s disease, pharmacists, knowledge, ADKS, dementia